pharma-话题@MedSci

#pharma#

608篇内容 | 2479人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1908669, encodeId=b3cf19086690d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：进展性间质性纤维化肺病的死亡率预测因子, objectType=article, longId=219584, objectId=57e1219584d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57e1219584d4, replyNumber=0, likeNumber=72, createdTime=2022-04-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57e1219584d4, moduleTitle=Front Pharmacol：进展性间质性纤维化肺病的死亡率预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57e1219584d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908652, encodeId=b8fb19086527b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：中医药联合肺部给药系统防治特发性肺纤维化可行性探讨, objectType=article, longId=215787, objectId=0a39215e873e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a39215e873e, replyNumber=0, likeNumber=71, createdTime=2021-11-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a39215e873e, moduleTitle=Biomed Pharmacother：中医药联合肺部给药系统防治特发性肺纤维化可行性探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a39215e873e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908658, encodeId=afa1190865844, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药, objectType=article, longId=217612, objectId=ab6b21e61271, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab6b21e61271, replyNumber=0, likeNumber=61, createdTime=2022-03-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab6b21e61271, moduleTitle=Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab6b21e61271)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908632, encodeId=96311908632ef, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Neuropsychopharmacology：神经黑色素敏感磁共振成像有助于监测多巴胺相关的精神运动减缓疾病, objectType=article, longId=212040, objectId=546a212040c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=546a212040c0, replyNumber=0, likeNumber=93, createdTime=2022-01-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=546a212040c0, moduleTitle=Neuropsychopharmacology：神经黑色素敏感磁共振成像有助于监测多巴胺相关的精神运动减缓疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=546a212040c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908663, encodeId=1bc5190866399, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关, objectType=article, longId=218302, objectId=3ada21830258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ada21830258, replyNumber=0, likeNumber=70, createdTime=2021-12-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ada21830258, moduleTitle=Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ada21830258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908651, encodeId=37981908651f6, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=万春医药CEO黄岚博士荣膺“PharmaVOICE生物科学100人”, objectType=article, longId=215697, objectId=ab2221569e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab2221569e71, replyNumber=0, likeNumber=118, createdTime=2022-06-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab2221569e71, moduleTitle=万春医药CEO黄岚博士荣膺“PharmaVOICE生物科学100人”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab2221569e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908654, encodeId=b5bb190865487, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Aliment Pharmacol Ther：炎症性肠病诊断前后的合并症, objectType=article, longId=216483, objectId=23742164837d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23742164837d, replyNumber=0, likeNumber=64, createdTime=2022-06-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23742164837d, moduleTitle=Aliment Pharmacol Ther：炎症性肠病诊断前后的合并症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23742164837d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908653, encodeId=ce8e19086532b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=FRONT PHARMACOL：非诺贝特可以将新冠感染减少超70%, objectType=article, longId=216024, objectId=0479216024a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0479216024a8, replyNumber=0, likeNumber=114, createdTime=2021-11-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0479216024a8, moduleTitle=FRONT PHARMACOL：非诺贝特可以将新冠感染减少超70%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0479216024a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908646, encodeId=620f190864644, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Aliment Pharmacol Ther：雷尼替丁是否会增加消化道癌症的风险？, objectType=article, longId=214801, objectId=b57b21480116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b57b21480116, replyNumber=0, likeNumber=69, createdTime=2022-07-06, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b57b21480116, moduleTitle=Aliment Pharmacol Ther：雷尼替丁是否会增加消化道癌症的风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b57b21480116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908639, encodeId=c4981908639cf, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Neuropsychopharmacology:人巨细胞病毒感染与重度抑郁症患者白质FA降低之间存在可复制关联, objectType=article, longId=213444, objectId=485d213444a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=485d213444a1, replyNumber=0, likeNumber=63, createdTime=2021-12-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=485d213444a1, moduleTitle=Neuropsychopharmacology:人巨细胞病毒感染与重度抑郁症患者白质FA降低之间存在可复制关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=485d213444a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908634, encodeId=88d91908634b0, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：间羟胺预防剖宫产术中脊麻性低血压的随机双盲剂量依赖性研究, objectType=article, longId=212839, objectId=48a921283922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48a921283922, replyNumber=0, likeNumber=61, createdTime=2022-03-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48a921283922, moduleTitle=Front Pharmacol：间羟胺预防剖宫产术中脊麻性低血压的随机双盲剂量依赖性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48a921283922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908668, encodeId=c39019086682a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Br J Pharmacol：阿米替林阻断TLR4和IL1R介导的先天免疫反应：OA和痛风的临床前和临床证据, objectType=article, longId=219478, objectId=e1be2194e8b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1be2194e8b9, replyNumber=0, likeNumber=68, createdTime=2022-09-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1be2194e8b9, moduleTitle=Br J Pharmacol：阿米替林阻断TLR4和IL1R介导的先天免疫反应：OA和痛风的临床前和临床证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1be2194e8b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908640, encodeId=00ca190864045, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Aliment Pharmacol Ther：中心性肥胖的慢性乙肝患者发展成肝癌的风险增加了两倍！, objectType=article, longId=213448, objectId=4a2021344866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a2021344866, replyNumber=0, likeNumber=94, createdTime=2022-03-07, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a2021344866, moduleTitle=Aliment Pharmacol Ther：中心性肥胖的慢性乙肝患者发展成肝癌的风险增加了两倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a2021344866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908648, encodeId=a47a1908648b7, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Aliment Pharmacol Ther：泰戈拉赞vs.兰索拉唑治疗胃溃疡的效果, objectType=article, longId=214846, objectId=a4bf2148463c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4bf2148463c, replyNumber=0, likeNumber=70, createdTime=2022-02-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4bf2148463c, moduleTitle=Aliment Pharmacol Ther：泰戈拉赞vs.兰索拉唑治疗胃溃疡的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4bf2148463c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908623, encodeId=d5411908623e7, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据, objectType=article, longId=207251, objectId=158620e25189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=158620e25189, replyNumber=0, likeNumber=114, createdTime=2021-12-09, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=158620e25189, moduleTitle=Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=158620e25189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908626, encodeId=349a1908626a6, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Ethnopharmacol：Ashwagandha根提取物可以提高睡眠质量，有助于管理失眠, objectType=article, longId=208218, objectId=1fc520821824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fc520821824, replyNumber=0, likeNumber=78, createdTime=2021-10-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fc520821824, moduleTitle=J Ethnopharmacol：Ashwagandha根提取物可以提高睡眠质量，有助于管理失眠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fc520821824)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908619, encodeId=12781908619b7, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Octapharma将在EAHAD第14届年会上展示改善血友病A患者长期健康的长期承诺, objectType=article, longId=205696, objectId=7c49205696e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c49205696e4, replyNumber=0, likeNumber=61, createdTime=2021-12-22, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c49205696e4, moduleTitle=Octapharma将在EAHAD第14届年会上展示改善血友病A患者长期健康的长期承诺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c49205696e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908657, encodeId=08e0190865e02, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Frontiers pharmacol：中医药治疗抑郁症合并糖尿病前景光明, objectType=article, longId=217602, objectId=1aa221e602d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aa221e602d9, replyNumber=0, likeNumber=80, createdTime=2022-08-18, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aa221e602d9, moduleTitle=Frontiers pharmacol：中医药治疗抑郁症合并糖尿病前景光明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aa221e602d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908641, encodeId=ba5f1908641eb, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：肠道微生物群通过调节TLR4/NF-kB信号通路对抗LPS引起的急性肺损伤, objectType=article, longId=214156, objectId=f054214156bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f054214156bc, replyNumber=0, likeNumber=92, createdTime=2022-05-07, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f054214156bc, moduleTitle=Int Immunopharmacol：肠道微生物群通过调节TLR4/NF-kB信号通路对抗LPS引起的急性肺损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f054214156bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908620, encodeId=600b1908620f8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒, objectType=article, longId=205740, objectId=214b205e4021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=214b205e4021, replyNumber=0, likeNumber=59, createdTime=2021-12-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=214b205e4021, moduleTitle=ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=214b205e4021)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

pharma

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：进展性间质性纤维化肺病的死亡率预测因子

2022-04-05

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：中医药联合肺部给药系统防治特发性肺纤维化可行性探讨

2021-11-23

chentianping (审核中...)

前往app查看评论内容

#pharma#

Rhizen Pharmaceuticals AG宣布，RP7214治疗新冠肺炎患者2期研究进行首例患者给药

2022-03-01

chentianping (审核中...)

前往app查看评论内容

#pharma#

Neuropsychopharmacology：神经黑色素敏感磁共振成像有助于监测多巴胺相关的精神运动减缓疾病

2022-01-22

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关

2021-12-17

chentianping (审核中...)

前往app查看评论内容

#pharma#

万春医药CEO黄岚博士荣膺“PharmaVOICE生物科学100人”

2022-06-26

chentianping (审核中...)

前往app查看评论内容

#pharma#

Aliment Pharmacol Ther：炎症性肠病诊断前后的合并症

2022-06-15

chentianping (审核中...)

前往app查看评论内容

#pharma#

FRONT PHARMACOL：非诺贝特可以将新冠感染减少超70%

2021-11-27

chentianping (审核中...)

前往app查看评论内容

#pharma#

Aliment Pharmacol Ther：雷尼替丁是否会增加消化道癌症的风险？

2022-07-06

chentianping (审核中...)

前往app查看评论内容

#pharma#

Neuropsychopharmacology:人巨细胞病毒感染与重度抑郁症患者白质FA降低之间存在可复制关联

2021-12-31

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：间羟胺预防剖宫产术中脊麻性低血压的随机双盲剂量依赖性研究

2022-03-04

chentianping (审核中...)

前往app查看评论内容

#pharma#

Br J Pharmacol：阿米替林阻断TLR4和IL1R介导的先天免疫反应：OA和痛风的临床前和临床证据

2022-09-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

Aliment Pharmacol Ther：中心性肥胖的慢性乙肝患者发展成肝癌的风险增加了两倍！

2022-03-07

chentianping (审核中...)

前往app查看评论内容

#pharma#

Aliment Pharmacol Ther：泰戈拉赞vs.兰索拉唑治疗胃溃疡的效果

2022-02-04

chentianping (审核中...)

前往app查看评论内容

#pharma#

Modra Pharmaceuticals于2021 ASCO GU年会公布其转移性前列腺癌IIb期临床试验初步数据

2021-12-09

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Ethnopharmacol：Ashwagandha根提取物可以提高睡眠质量，有助于管理失眠

2021-10-26

docwu2019 (审核中...)

前往app查看评论内容

#pharma#

Octapharma将在EAHAD第14届年会上展示改善血友病A患者长期健康的长期承诺

2021-12-22

chentianping (审核中...)

前往app查看评论内容

#pharma#

Frontiers pharmacol：中医药治疗抑郁症合并糖尿病前景光明

2022-08-18

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：肠道微生物群通过调节TLR4/NF-kB信号通路对抗LPS引起的急性肺损伤

2022-05-07

chentianping (审核中...)

前往app查看评论内容

#pharma#

ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒

2021-12-25

科室
- - 订阅+
  - 更多科室
工具
服务